°F .   H  e  w  a  s  n  o  t  e  d  t  o  h  a  v  e  s  p  l  e  n  o  m  e  g  a  l  y  ,  p  a  n  c  y  t  o  p  e  n  i  a  w  i  t  h  a  n   a  b  s  o  l  u  t  e  n  e  u  t  r  o  p  h  i  l  c  o  u  n  t  (  A  N  C  )  o  f  7  2  6  ,  e  l  e  v  a  t  e  d  f  e  r  r  i  t  i  n  o  f  9  2  4  µ  g  /  L  ,  e  l  e  v  a  t  e  d For personal use only. on May 29, 2017 . by guest www.bloodjournal.org From t  r  a  n  s  a  m  i  n  a  s  e  s  ,  a  n  d  d  i  f  f  u  s  e  p  u  l  m  o  n  a  r  y  i  n  f  i  l  t  r  a  t  e  s  o  n  c  h  e  s  t  C  T  .  H  e  w  a  s  b  e  g  u  n  o  n   e  m  p  i  r  i  c  b  r  o  a  d  -s  p  e  c  t  r  u  m  a  n  t  i  b  i  o  t  i  c  s  .  B  o  n  e  m  a  r  r  o  w  b  i  o  p  s  y  r  e  v  e  a  l  e  d  a  h  y  p  e  r  c  e  l  l  u  l  a  r   m  a  r  r  o  w  w  i  t  h  m  a  t  u  r  i  n  g  t  r  i  l  i  n  e  a  g  e  h  e  m  a  t  o  p  o  i  e  s  i  s  ,  v  i  r  t  u  a  l  l  y  a  b  s  e  n  t  i  r  o  n  s  t  o  r  e  s  ,  a  n  d   v  e  r  y  r  a  r  e  h  e  m  o  p  h  a  g  o  c  y  t  o  s  i  s  .  B  o  n  e  m  a  r  r  o  w  f  l  o  w  c  y  t  o  m  e  t  r  y  s  h  o  w  e  d  n  o  c  l  o  n  a  l   p  o  p  u  l  a  t  i  o  n  s  .  E  x  t  e  n  s  i  v  e  i  n  f  e  c  t  i  o  u  s  w  o  r a homozygous T272C (A91V) mutation in the gene encoding perforin 1 (PRF1), a gene commonly implicated in primary HLH. He was given alemtuzumab followed by matched related donor reduced-intensity hematopoietic stem cell transplantation (MRD RIC HSCT). He engrafted successfully and has had no recurrent HLH >1 year after transplant. A bone marrow biopsy was performed and was suggestive of evolving MDS. She was discharged and followed as an outpatient by hematology, where she had fevers to 102.7°F A 38-year-old male was referred to our institution with a new diagnosis of primary cutaneous gamma delta T cell lymphoma. He had been in excellent health until 3 months prior when he presented to his primary care physician with persistent symptoms of sinusitis. Despite treatment with a course of antibiotics, his symptoms progressed and he developed drenching night sweats, anorexia with 40lb weight loss, fatigue, and multiple subcutaneous nodules on his trunk and legs. An extensive work-up revealed primary cutaneous gamma delta T cell lymphoma and he was referred to our institution for treatment. On initial evaluation he was found to also have HLH with splenomegaly in addition to thrombocytopenia, borderline neutropenia, hypofibrinogenemia, hypertriglyceridemia, elevated transaminases, hyperferritinemia, and elevated sIL2R. He was started on an etoposide-containing chemotherapy regimen with 2 cycles of CHOEP. Follow-up PET scan showed a mixed response, so this was stopped and he received 3 cycles of GEM-OX followed by 2 cycles of romidepsin. This course was complicated by multiple admissions for fever and an episode of clostridium difficile. His lymphoma initially responded well to this therapy but he was admitted 5 months after initial presentation with progressive disease. He was started on dexamethasone and ICE but unfortunately shortly after initiation developed worsening mental status and treatment goals were changed to comfort measures. Autopsy revealed widespread lymphoma in addition to fungal bronchopneumonia and evidence of candidemia. For 
